AstraZeneca Sues Pharmacy Over “Bait And Switch” Tactic With Popular Asthma Drug

Law360, New York (September 6, 2005, 12:00 AM EDT) -- AstraZeneca has sued a manufacturer for trademark infringement and false advertising under the Lanham Act, alleging a copycat version of its inhaled asthma medication Pulmicort Respules is forced on unsuspecting customers.

Connecticut-based Broncho-Dose is a mail order “repertory pharmacy” that allegedly engages in the “often abused practice” of pre-mixing its own non-FDA-approved drugs, according to the complaint. Broncho then distributes the drugs as substitutes for various products, including the product in this suit.

Delaware-based AstraZeneca does not allege the Broncho version of the medication is too...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.